Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
175 studies found for:    Open Studies | "Venous Thrombosis"
Show Display Options
Rank Status Study
1 Recruiting Outcome of Percutaneous Mechanical Thrombectomy to Treat Acute Deep Venous Thrombosis
Condition: Deep Venous Thrombosis
Intervention: Procedure: Percutaneous mechanical thrombectomy
2 Recruiting The Role of Factor XIII Activation Peptide and D-dimer Values for the Diagnosis of Cerebral Venous Thrombosis (CVT)
Condition: Cerebral Venous Thrombosis
Intervention: Other: ELISA Test
3 Recruiting Comparison Between Xarelto Versus Warfarin in the Recanalization Rate of Deep Venous Thrombosis in Patients Legs.
Condition: Deep Venous Thrombosis
Interventions: Drug: Rivaroxaban;   Drug: Warfarin
4 Recruiting Study to Assess Safety, Tolerability, and Efficacy of GMI-1271 in Patients With Calf-level Deep Venous Thrombosis (DVT)
Condition: Deep Venous Thrombosis
Interventions: Drug: GMI-1271;   Drug: Enoxaparin Sodium (Lovenox®)
5 Recruiting Study on the Incidence of Early Deep Vein Thrombosis After Peripherally Inserted Central Catheter Insertion
Condition: Venous Thrombosis
Intervention:
6 Recruiting Apixaban as Treatment of Venous Thrombosis in Patients With Cancer: The CAP Study
Conditions: Neoplasms;   Venous Thrombosis
Intervention: Drug: Apixaban
7 Recruiting Rivaroxaban for Scheduled Work-up of DVT - The Ri-Schedule Study
Condition: Deep Venous Thrombosis
Intervention: Drug: Rivaroxaban
8 Recruiting Immature Plateletes in the Etiopathology of Deep Venous Thrombosis
Conditions: Immature Platelets;   Deep Venous Thrombosis
Intervention: Other: Blood samples
9 Not yet recruiting Tranexamic Acid and Blood Clots in Knee Surgery
Condition: Venous Thrombosis
Intervention: Drug: Tranexamic Acid
10 Recruiting Rivaroxaban Anticoagulation for Superficial Vein Thrombosis
Condition: Symptomatic Superficial Vein Thrombosis
Interventions: Drug: Rivaroxaban;   Drug: Placebo
11 Recruiting The Designer D-dimer Deep Vein Thrombosis Diagnosis (4D) Study
Condition: Suspected Deep Vein Thrombosis
Intervention:
12 Not yet recruiting Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trial
Conditions: Deep Vein Thrombosis;   Post-Thrombotic Syndrome;   Venous Thrombosis
Interventions: Drug: Recombinant tissue plasminogen activator (rt-PA);   Drug: Standard Anticoagulation Therapy
13 Recruiting Doppler Ultrasound Imaging of Plastic Surgery Patients for DVT Detection
Condition: Deep Venous Thrombosis
Intervention:
14 Recruiting Osteopathic Treatment and Deep Vein Thrombosis (DVT)
Condition: Deep Vein Thrombosis (DVT)
Intervention: Other: Osteopathic Treatment
15 Not yet recruiting Rivaroxaban for the Treatment of Symptomatic Isolated Distal Deep Vein Thrombosis
Condition: Deep Vein Thrombosis
Interventions: Drug: rivaroxaban;   Drug: Placebo
16 Recruiting D-dimer and Pre-test Clinical Probability Score in Cancer Patients With Suspected Deep Vein Thrombosis of the Legs
Condition: Deep Vein Thrombosis
Intervention: Other: Diagnostic tests for suspected deep vein thrombosis
17 Recruiting INvestigating SIGnificant Health TrendS in the Management of Superficial Vein Thrombosis
Condition: Superficial Vein Thrombosis
Interventions: Drug: any drug;   Procedure: any procedure/surgery;   Other: Any non-pharmacological treatment of SVT
18 Recruiting Xarelto Versus no Treatment for the Prevention of Recurrent Thrombosis in Patients With Chronic Portal Vein Thrombosis.
Conditions: Deep Vein Thrombosis;   Chronic Portal Vein Thrombosis
Intervention: Drug: Xarelto
19 Recruiting Rosuvastatin Use to Improve the Coagulation Profile in Patients With Venous Thrombosis
Conditions: Deep Vein Thrombosis;   Pulmonary Embolism
Intervention: Drug: Rosuvastatin
20 Recruiting Randomized Controlled Trial of Anticoagulation vs. Placebo for a First Symptomatic Isolated Distal Deep-vein Thrombosis (IDDVT)
Condition: Distal (Calf) Deep-vein Thrombosis
Interventions: Drug: nadroparine calcium;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.